Our client was seeking to develop an evidence base to support the contribution of personalised medicines to patients, healthcare systems and society more broadly, and identify hurdles and enablers to the development and adoption of personalised medicines in Europe
CRA Approach
- Reviewed evidence of benefits of personalised medicines through literature review and expert interviews
- Identified appropriate analogues and conducted case study assessments of analogue impact in each key EU market
- Developed advocacy plan and recommendations to support awareness of personalised medicines and their potential in advancing healthcare
Client Impact
- Comprehensive evidence base demonstrating benefit of personalised medicines, including a range of supportive case studies
- Strategic, actionable advocacy plan to improve adoption of personalised medicines and enable efficiencies within existing healthcare systems
